Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending May 2014. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, rather than a financial results announcement.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is limited to reporting a specific insider transaction.
Material Changes
The only material event reported is a change in the interests of Mr. J Ford, a Person Discharging Managerial Responsibility. On May 1, 2014, Mr. Ford sold 5,874 American Depositary Shares (ADSs) of GlaxoSmithKline plc at a price of $55.543 per ADS.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, risks, contingencies, or unusual items. It strictly adheres to the Disclosure and Transparency Rules regarding the notification of the aforementioned transaction.
Investor Verification Points
- Verify the total number of ADSs sold by Mr. J Ford (5,874 shares).
- Confirm the transaction date (May 1, 2014) and execution price ($55.543 per ADS).
- Note that this filing does not contain quarterly or annual financial performance data.